On October 1, Ronie Schmelz spoke at the Global Synthetic Biology Conference, an impactful event to unite leading biological engineers, investors, innovators, and entrepreneurs. Ronie was part of panel discussing “The Microbiome: From Decoding Nature to Biotech Breakthroughs,” focusing on the latest in microbiome research, natural versus engineered treatments and how they might coexist, and a road map to navigate a regulatory framework that was not built for synthetic biology, live interventions, and personalized medicine.